Medicare Enrolled

Dr. John Wald, M.D.

Neurology · Jackson, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1201 E MICHIGAN AVE, Jackson, MI 49201
5178177620
In practice since 2006 (19 years)
NPI: 1275627366 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wald from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wald? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wald

Dr. John Wald is a neurology specialist in Jackson, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Wald performed 840 Medicare services across 544 unique beneficiaries.

Between the years covered by Open Payments, Dr. Wald received a total of $458,694 from 47 pharmaceutical and/or device companies across 1110 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wald is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 19% volume in MI $458,694 industry payments

Medicare Practice Summary

Medicare Utilization ↗
840
Medicare services
Top 19% in MI for neurology
544
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~44 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
282 $98 $159
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
122 $61 $110
Bilateral facial and neck nerve muscle paralysis injection
Injection of a chemical agent to paralyze muscles in the face and neck on both sides.
95 $89 $430
Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle 90 $14 $63
Chemical nerve block for neck muscles
Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box.
69 $119 $762
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
68 $32 $169
Chemical nerve block for facial paralysis
Injection of a chemical agent to paralyze specific nerves or muscles on the side of the face.
30 $122 $774
Nerve conduction study, 3-4 tests
A diagnostic test that measures how well nerves send electrical signals. It involves performing 3 to 4 separate nerve conduction studies to evaluate nerve function.
22 $46 $212
Smoking cessation counseling, 4-10 minutes
A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation.
20 $11 $20
Nerve conduction studies, 5-6 tests
A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction.
15 $56 $253
New patient office visit, complex (60-74 min) 15 $119 $207
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
12 $68 $122
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$458,694
Total received (2018-2024)
Avg $65,528/year across 7 years
Top 2% in MI for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
1,110
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$454,107 (99.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,280 (0.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$307 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$28,091
2023
$34,705
2022
$80,338
2021
$109,723
2020
$69,114
2019
$59,742
2018
$76,982

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$16,856
Teva Pharmaceuticals USA, Inc.
$11,178
Kyowa Kirin, Inc.
$57
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$128,799
Allergan, Inc.
$89,530
AbbVie Inc.
$55,195
ABBVIE INC.
$53,379
Amgen Inc.
$44,523
Allergan Inc.
$27,891
GENZYME CORPORATION
$27,202
Biohaven Pharmaceuticals, Inc.
$16,028
PFIZER INC.
$11,030
BANNER LIFE SCIENCES, LLC
$900
Novartis Pharmaceuticals Corporation
$584
Biogen, Inc.
$539
Adamas Pharmaceuticals, Inc.
$500
UCB, Inc.
$459
Genentech USA, Inc.
$382
EMD Serono, Inc.
$249
Janssen Pharmaceuticals, Inc
$228
Supernus Pharmaceuticals, Inc.
$225
Abbott Laboratories
$153
Kyowa Kirin, Inc.
$146
ACADIA Pharmaceuticals Inc
$91
CSL Behring
$59
Assertio Therapeutics, Inc.
$55
Neurocrine Biosciences, Inc.
$41
Biohaven Pharmaceutical Holding Company Ltd.
$38
Sunovion Pharmaceuticals Inc.
$37
AbbVie, Inc.
$36
US WorldMeds, LLC
$36
Acorda Therapeutics, Inc
$35
Avanir Pharmaceuticals, Inc.
$35
Avion Pharmaceuticals
$27
Celgene Corporation
$27
Neurelis, Inc.
$25
Mitsubishi Tanabe Pharma America, Inc.
$25
Alexion Pharmaceuticals, Inc.
$18
Impax Laboratories, Inc.
$17
EISAI INC.
$17
Lundbeck LLC
$16
Eisai Inc.
$16
Currax Pharmaceuticals LLC
$15
NEUROPACE, INC.
$15
Egalet US Inc
$14
Advanced Respiratory, Inc
$13
Ipsen Biopharmaceuticals, Inc
$12
Kaleo, Inc.
$11
Upsher-Smith Laboratories LLC
$11
Lilly USA, LLC
$11
Top 3 companies account for 59.6% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AIMOVIG · AJOVY · AMPLATZER Occluders · AMPYRA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX COSMETIC · BOTOX THERAPEUTIC · Briviact · CONTRAVE · COPAXONE · Duopa · Dysport · EMGALITY · Evzio · Fycompa · GILENYA · GOCOVRI · Gralise · Hizentra · INBRIJA · INGREZZA · KESIMPTA · LEMTRADA · LYRICA · MAYZENT · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · OCREVUS · ONGENTYS · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RNS System · RYTARY · Radicava · Rebif · SOLIRIS · SPRIX · TECFIDERA · TROKENDI XR · TYSABRI · The Vest System Model 105 Home Care · UBRELVY · VALTOCO · VRAYLAR · VUMERITY · Xadago · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (99%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for neurology in MI.

Looking for a neurology specialist in Jackson?
Compare neurologists in the Jackson area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
6
Per 100K population
3.7
County median income
$65,004
Nearest hospital
HENRY FORD ALLEGIANCE HEALTH
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Wald is a clinical cardiology specialist, with above-average Medicare volume (top 19% in MI), with speaking/promotional industry engagement in the top 2% of MI peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Wald experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Wald performed 282 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wald receive payments from pharmaceutical companies?
Yes. Dr. Wald received a total of $458,694 from 47 companies across 1,110 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wald's costs compare to other neurologists in Jackson?
Dr. Wald's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wald) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →